Sweden· SE-20230928000200
ANDEMBRY 200 mg Injektionsvätska, lösning i förfylld injektionspenna
A medicinal product containing garadacimab, registered in Sweden by CSL Behring GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Garadacimab
- Manufacturer
- CSL Behring GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20230928000200
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Garadacimab in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANDEMBRYCSL Behring GmbH, Marburg
- IcelandAndembryCSL Behring GmbH*
- BelgiumAndembry 200 mgCSL Behring
- PolandAndembryCSL Behring GmbH
- NorwayAndembryCSL Behring GmbH
- SpainANDEMBRY 200 MG SOLUCION INYECTABLE EN PLUMA PRECARGADACsl Behring Gmbh
- FinlandANDEMBRYCSL Behring GmbH
- IrelandANDEMBRY 200 mg solution for injection in pre-filled penCSL Behring GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Andembry
- Liechtenstein · Andembry
- Norway · Andembry
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/facbfe4e-0a82-40f6-a5f4-bf39386eea69 GET /v1/drugs/facbfe4e-0a82-40f6-a5f4-bf39386eea69?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20230928000200",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20230928000200",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/andembry-epar-product-information_sv.pdf"
}See everything about garadacimab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.